PL vs. ASND
PL (Planet Labs PBC) and ASND (Ascendis Pharma A/S) are both stocks. PL operates in Aerospace & Defense (Industrials), while ASND operates in Biotechnology (Healthcare). Over the past 5 years, PL returned 25.63%/yr vs 10.86%/yr for ASND. At a 0.24 correlation, their price movements are largely independent.
Performance
PL vs. ASND - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PL achieves a 57.96% return, which is significantly higher than ASND's 2.26% return.
PL
- 1D
- -8.84%
- 1M
- -25.16%
- YTD
- 57.96%
- 6M
- 70.78%
- 1Y
- 480.07%
- 3Y*
- 106.65%
- 5Y*
- 25.63%
- 10Y*
- —
ASND
- 1D
- 1.14%
- 1M
- -9.33%
- YTD
- 2.26%
- 6M
- -1.07%
- 1Y
- 27.67%
- 3Y*
- 32.88%
- 5Y*
- 10.86%
- 10Y*
- 33.14%
PL vs. ASND - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
PL Planet Labs PBC | 57.96% | 388.12% | 63.56% | -43.22% | -29.27% | -37.24% |
ASND Ascendis Pharma A/S | 2.26% | 54.89% | 9.31% | 3.13% | -9.22% | 1.86% |
Correlation
The correlation between PL and ASND is 0.10, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Apr 26, 2021 | 0.24 |
The correlation between PL and ASND shifts across timeframes, from 0.10 (1 year) to 0.25 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
PL:
$10.76B
ASND:
$14.07B
PL:
-$1.17
ASND:
€8.08
PL:
29.61
ASND:
13.62
PL:
24.26
ASND:
24.89
PL:
$335.61M
ASND:
€867.51M
PL:
$186.28M
ASND:
€764.89M
PL:
-$125.70M
ASND:
-€6.94M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PL vs. ASND — Risk / Return Rank
PL
ASND
PL vs. ASND - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Planet Labs PBC (PL) and Ascendis Pharma A/S (ASND). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PL | ASND | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.87 | ||
| Sortino ratioReturn per unit of downside risk | +2.88 | ||
| Omega ratioGain probability vs. loss probability | 1.55 | 1.15 | +0.40 |
| Calmar ratioReturn relative to maximum drawdown | 11.79 | 1.59 | +10.20 |
| Martin ratioReturn relative to average drawdown | 36.80 | 4.87 | +31.93 |
Loading charts...
Drawdowns
PL vs. ASND - Drawdown Comparison
The maximum PL drawdown since its inception was -85.73%, which is greater than ASND's maximum drawdown of -61.72%. Use the drawdown chart below to compare losses from any high point for PL and ASND.
Loading charts...
Drawdown Indicators
| PL | ASND | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -85.73% | -61.72% | -24.01% |
Max Drawdown (1Y)Largest decline over 1 year | -40.23% | -17.62% | -22.61% |
Max Drawdown (3Y)Largest decline over 3 years | -55.17% | -29.15% | -26.02% |
Max Drawdown (5Y)Largest decline over 5 years | -85.73% | -60.46% | -25.27% |
Max Drawdown (10Y)Largest decline over 10 years | — | -61.72% | — |
Current DrawdownCurrent decline from peak | -39.40% | -12.72% | -26.68% |
Average DrawdownAverage peak-to-trough decline | -49.90% | -18.90% | -31.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.88% | 5.72% | +7.16% |
Volatility
PL vs. ASND - Volatility Comparison
Planet Labs PBC (PL) has a higher volatility of 39.48% compared to Ascendis Pharma A/S (ASND) at 13.12%. This indicates that PL's price experiences larger fluctuations and is considered to be riskier than ASND based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PL | ASND | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 39.48% | 13.12% | +26.36% |
Volatility (6M)Calculated over the trailing 6-month period | 78.71% | 29.45% | +49.26% |
Volatility (1Y)Calculated over the trailing 1-year period | 102.61% | 37.26% | +65.35% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 80.98% | 48.65% | +32.33% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 79.91% | 51.09% | +28.82% |
Dividends
PL vs. ASND - Dividend Comparison
Neither PL nor ASND has paid dividends to shareholders.
Financials
PL vs. ASND - Financials Comparison
This section allows you to compare key financial metrics between Planet Labs PBC and Ascendis Pharma A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
PL and ASND have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PL has higher volatility (39.48%) compared to ASND (13.12%). In terms of maximum drawdown, PL dropped -85.73% vs ASND's -61.72%.
PL currently has the higher Sharpe Ratio (4.62 vs 0.75), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PL and ASND
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer